VENN STRATEGIES

Lobbying for PACIRA PHARMACEUTICALS INC. · Pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $90,000.00 income · posted Jul 17, 2026

Lobbying activity 1

Health Issues

Improving access to non-opioid approaches to pain management.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem